Back to search

Article

Ergothioneine Supplementation and Patient-Reported Urological Symptoms in Adults with Mildly Reduced or Borderline Renal Function: An Exploratory Open-Label Trial

2026-07-09

Abstract excerpt

<h4>Background</h4> Early renal function decline is often accompanied by bothersome urological symptoms, yet effective early-stage nutritional interventions remain limited. L-Ergothioneine (EGT), a diet-derived antioxidant concentrated in renal tissue via the OCTN1 transporter, has shown renoprotective potential preclinically, but human interventional data are sparse. <h4>Methods</h4> In this single-center, open...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
83d2abc1-dd9d-55e7-b3b5-30c679e950be
DOI
10.64898/2026.07.08.26356008
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ergothioneine Supplementation and Patient-Reported Urological Symptoms in Adults with Mildly Reduced or Borderline Renal Function: An Exploratory Open-Label TrialDOI 10.64898/2026.07.08.26356008
Oral Gene III <sup>®</sup> L-Ergothioneine Capsules in Women with Suboptimal Ovarian Reserve: A Single-Center, Open-Label, Self-Controlled Pilot Study of Ovarian Reserve Markers, Endocrine Profiles, and Reproductive Aging-Related SymptomsSemantic proximity
Efficacy and Safety of Oral Gene III <sup>®</sup> L-Ergothioneine Capsules in Primary Dysmenorrhea: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialSemantic proximity
Safety and Exploratory Efficacy of Reduced β-Nicotinamide Mononucleotide Calcium Salt (NMNH-Ca) in Healthy Middle-Aged and Older Adults: A Randomized, Double-Blind, Placebo-Controlled TrialSemantic proximity
Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary careSemantic proximity
Hepatoprotective Efficacy of GeneIII <sup>®</sup> L-Ergothioneine Capsules: A Self-Controlled Clinical TrialSemantic proximity
Association between serum chloride levels and estimated glomerular filtration rate among US adults: evidence from NHANES 1999 - 2018Semantic proximity
Diet-Derived Antioxidants: The Special Case of ErgothioneineSemantic proximity
A comparison of the natriuretic and kaliuretic effects of cicletanine and hydrochlorothiazide in prehypertensive and hypertensive humans.Semantic proximity
The potential therapeutic effects of ergothioneine in pre-eclampsiaSemantic proximity
Effectivity and Safety Profile of Tenapanor, a Sodium-Hydrogen Exchanger Isoform 3 Inhibitor, as an Innovative Treatment for Hyperphosphatemia in Chronic Kidney Disease, a Systematic Review of Clinical StudiesSemantic proximity
The Effect of Thiazide Diuretics on Urinary Prostaglandin E2 Excretion and Serum Sodium in the General Population.Semantic proximity
Associations between chronic kidney disease and mental health disorders and psychoactive drugs in the UK general populationSemantic proximity
Select a neighboring publication to make it the new centre.